Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Subramanyam

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Medicine|September 6, 2016
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effectMaría José Ortuño, Samuel T Robinson, Prakash Subramanyam, et al.
The Journal of Clinical Investigation|November 14, 2018
Cardiac CaV1.2 channels require β subunits for β-adrenergic-mediated modulation but not traffickingLin Yang, Alexander Katchman, Jared Kushner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2026
Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studiesRavindranath Reddy Gilibili, Simmi Gupta, Anup Arunrao Deshpande, et al.
JCI Insight|September 8, 2017
Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial functionLeroy C Joseph, Dimitra Kokkinaki, Mesele-Christina Valenti, et al.
Circulation. Arrhythmia and Electrophysiology|November 1, 2019
Dietary Saturated Fat Promotes Arrhythmia by Activating NOX2 (NADPH Oxidase 2)Leroy C Joseph, Uma Mahesh R Avula, Elaine Y Wan, et al.
Haematologica|November 9, 2023
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidaseDanny V Jeyaraju, Maryam Alapa, Ann Polonskaia, et al.
Elife|July 20, 2016
Structural mechanism of ligand activation in human calcium-sensing receptorYong Geng, Lidia Mosyak, Igor Kurinov, et al.
Blood Neoplasia|February 2, 2026
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myelomaChad C Bjorklund, Marta Larrayoz, Jian Kang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Medicine|September 6, 2016
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effectMaría José Ortuño, Samuel T Robinson, Prakash Subramanyam, et al.
The Journal of Clinical Investigation|November 14, 2018
Cardiac CaV1.2 channels require β subunits for β-adrenergic-mediated modulation but not traffickingLin Yang, Alexander Katchman, Jared Kushner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2026
Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studiesRavindranath Reddy Gilibili, Simmi Gupta, Anup Arunrao Deshpande, et al.
JCI Insight|September 8, 2017
Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial functionLeroy C Joseph, Dimitra Kokkinaki, Mesele-Christina Valenti, et al.
Circulation. Arrhythmia and Electrophysiology|November 1, 2019
Dietary Saturated Fat Promotes Arrhythmia by Activating NOX2 (NADPH Oxidase 2)Leroy C Joseph, Uma Mahesh R Avula, Elaine Y Wan, et al.
Haematologica|November 9, 2023
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidaseDanny V Jeyaraju, Maryam Alapa, Ann Polonskaia, et al.
Elife|July 20, 2016
Structural mechanism of ligand activation in human calcium-sensing receptorYong Geng, Lidia Mosyak, Igor Kurinov, et al.
Blood Neoplasia|February 2, 2026
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myelomaChad C Bjorklund, Marta Larrayoz, Jian Kang, et al.
Pageof 2